On The Pen With Dave Knapp

Dave Knapp Man On The Mounjaro, Bleav
  • 0.0 (0)
  • MEDICINE
  • UPDATED WEEKLY

Dave Knapp brings you your weekly dose of everything in the news about incretin mimetic, diabetes and obesity therapies, like Zepbound and Mounjaro, Ozempic and Wegovy, and even investigational treatments like CagriSema and Retatrutide!

  1. Mounjaro Hair Loss + NFL Lineman Discovers Power in Personalized Medicine

    1 DAY AGO

    Mounjaro Hair Loss + NFL Lineman Discovers Power in Personalized Medicine

    otplinks.com stallybrand.com (code OTP10) Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    1h 11m
  2. Stopping Zepbound and Maintaining with Revita

    3 DAYS AGO

    Stopping Zepbound and Maintaining with Revita

    otplinks.com Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    42 min
  3. GLP-1 Treatment and Advocacy with Dr. Leslie Golden

    26 SEPT

    GLP-1 Treatment and Advocacy with Dr. Leslie Golden

    https://linktr.ee/manonthemounjaro Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    1h 17m
  4. Pfizer GLP-1 Play Worth $7.3B + Compound Tirzepatide Update

    23 SEPT

    Pfizer GLP-1 Play Worth $7.3B + Compound Tirzepatide Update

    https://linktr.ee/manonthemounjaro Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    34 min
  5. GLP-1 Weight Loss, Why It's About So Much More for Patients

    19 SEPT

    GLP-1 Weight Loss, Why It's About So Much More for Patients

    View All Our Links and Resources! Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    50 min
  6. Compound GLP-1 Legislation + FDA Warning Letter to HIMS

    16 SEPT

    Compound GLP-1 Legislation + FDA Warning Letter to HIMS

    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    44 min
  7. FDA CRACKDOWN on Compounded GLP-1s | Novo’s Gut Hack & Lilly’s One-Shot Cure

    9 SEPT

    FDA CRACKDOWN on Compounded GLP-1s | Novo’s Gut Hack & Lilly’s One-Shot Cure

    🔗 My Linktree with all resources: LINktr.ee/manonthemounjaro

    39 min
  8. Is Wegovy Better Than Zepbound? Plus the First Obesity GLP-1 Generic is Here!

    2 SEPT

    Is Wegovy Better Than Zepbound? Plus the First Obesity GLP-1 Generic is Here!

    Visit All Our Links https://linktr.ee/manonthemounjaro GLP-1 Heart Study https://onthepen.substack.com/p/new-study-glp-1-drugs-protect-the Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    26 min
See All (147)

About

Dave Knapp brings you your weekly dose of everything in the news about incretin mimetic, diabetes and obesity therapies, like Zepbound and Mounjaro, Ozempic and Wegovy, and even investigational treatments like CagriSema and Retatrutide!

Information

  • Creator
    Dave Knapp Man On The Mounjaro, Bleav
  • Years Active
    2024 - 2025
  • Episodes
    147
  • Rating
    Explicit
  • Copyright
    © 2025 On The Pen With Dave Knapp
  • Show Website
    On The Pen With Dave Knapp

You Might Also Like